OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders	72
Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Netwo	29
A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder	26
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment	24
Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology	23
Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial	22
Antidepressant psychopharmacology: is inflammation a future target?	21
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study	19
Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials	16
A systematic review of studies with clinician-rated scales on the pharmacological treatment of delusional disorder	15
Managing dissociative symptoms following the use of esketamine nasal spray: a case report	15
Evaluation of long-acting injectable antipsychotics with the corresponding oral formulation in a cohort of patients with schizophrenia: a real-world study in Spain	14
The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study	14
Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study	14
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	12
Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial	12
5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control	12
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study	12
Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer’s disease	11
Efficacy and safety of brexpiprazole in acute management of psychiatric disorders: a meta-analysis of randomized controlled trials	11
Vortioxetine improves cognition in mild cognitive impairment	10
Clinical specificity profile for novel rapid acting antidepressant drugs	10
Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain	10
Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies	10
Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study	10

Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts	10
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study	9
Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding	9
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder	9
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?	9
Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorder	9
Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial	9
Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study	9
Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort	9
Atypical antipsychotics in the treatment of psychotic symptoms in Alzheimer’s disease: a systematic review	8
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial	8
Infection is associated with elevated serum concentrations of antipsychotic drugs	8
The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study	8
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms	8
Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression	8
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	7
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	7
Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence	7
Predictors of discontinuation and hospitalization during long-acting injectable antipsychotic treatment in patients with schizophrenia spectrum disorder	7
Estimation of lithium clearance in patients with bipolar disorder	7
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	7
Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventions	7
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report	7
Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study	7
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	6
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	6
Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data	6
Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019	6
Risk of conversion to bipolar disorder in patients with late-onset major depression	6
Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol	6
Clinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study	5
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial	5
Pharmacologic treatment of depression in Alzheimer’s disease	5
Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10	5
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study	5
Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review	5
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	5
Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study	5
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations	5
The importance of monitoring renal function and concomitant medication to avoid toxicity in patients taking lithium	5
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	5